<DOC>
	<DOCNO>NCT02817620</DOCNO>
	<brief_summary>The purpose pilot study assess beneficial effect spirulina water extract ( product name Spirulysat® ) compare placebo blood level ratio oxidize LDL / total LDL cholesterol subject metabolic syndrome 12 week consumption</brief_summary>
	<brief_title>Study Assess Antioxidant Efficacy Spirulina oxLDL Lipids Metabolism Subjects With Metabolic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<criteria>To eligible study , male female volunteer fulfil follow criterion ( assessment base medical examination perform V0 check V1 ) : Age 18 65 year ( limit include ) , BMI 25 35 kg/m² ( limit include ) , With metabolic syndrome define central obesity : waist circumference &gt; 94 cm man &gt; 80 cm woman associate least 2 observed criterion among : Fasting blood triglyceride &gt; 1.5 g/L and/or Fasting blood HDL cholesterol &lt; 0.4 g/L man &lt; 0.5 g/L woman and/or Fasting blood glucose level &gt; 1 g/L and/or Arterial pressure &gt; 130/85 mmHg antihypertensive treatment , For woman : non menopausal reliable contraception since least 3 month begin study agree keep entire duration study ( condom spermicide gel accept ) menopausal without hormone replacement therapy start stable dose since least 3 month begin study agree keep entire duration study , Weight stable +/ 5 % last 3 month , Non smoke tobacco consumption &lt; 10 cigarette / day , Good general mental health opinion investigator : clinically significant relevant abnormality medical history physical examination , Able willing participate study comply protocol procedure evidence dated sign informed consent form , Affiliated social security scheme , Agree register volunteer biomedical research file , After V0 biological analysis subject eligible study follow criterion : Blood fast lipid profile require therapeutic intervention mean professional recommendation ( AFSSAPS , 2005 ) . A rescreening occur 2 month exit study failure comply one inclusion criterion list . Volunteers follow criterion consider non eligible study ( assessment base medical examination perform V0 check V1 ) : Suffering metabolic disorder diabetes , uncontrolled thyroidal trouble ... , Suffering severe chronic disease ( e.g . cancer , HIV , renal failure , hepatic biliary disorder ongoing , chronic inflammatory digestive disease , arthritis chronic respiratory trouble , etc . ) gastrointestinal disorder find inconsistent conduct study investigator ( e.g . celiac disease ) , With history ischemic cardiovascular event , Having undergone recent surgical procedure ( le 6 month ) , Suffering uncontrolled hypertension ( systolic blood pressure ≥ 160 mmHg and/or diastolic blood pressure ≥ 100 mmHg ) , With know suspect food allergy intolerance hypersensitivity study product ' ingredient , Pregnant lactate woman intend become pregnant within 4 month ahead , Under cholesterol and/or lipidlowering treatment ( e.g . statin , fibrates , ezetimibe , bile acid sequestrants , niacin , etc . ) stop less 3 month V0 visit , Under medication could affect blood lipid parameter ( e.g . longterm corticosteroid systemic drug , systemic antibody , androgen enzyme inducer , etc . ) stop less 3 month V0 visit ( antihypertensive stable longterm treatment tolerate ) , Regular intake dietary supplement `` functional food '' know impact lipid metabolism ( e.g . rich plant stanol sterol like PROACTIV DANACOL product , red yeast rice , policosanol , capsule contain omega3 fatty acid fish oil , etc . ) stop less 3 month V0 visit , Under treatment dietary supplement could significantly affect parameter ( ) follow study accord investigator stop short period V0 visit , With significant change food habit physical activity 3 month V0 visit agree keep unchanged throughout study , With current plan next 4 month specific diet ( hyper hypocaloric , vegan , vegetarian ... ) stop less 3 month V0 visit , With personal history anorexia nervosa , bulimia significant eating disorder accord investigator , Consuming 3 standard drink alcoholic beverage daily men 2 daily woman agree keep alcohol consumption habit unchanged throughout study , Having lifestyle deem incompatible study accord investigator include high level physical activity ( define 10 hour significant physical activity week , walk exclude ) , Who make blood donation 3 month V0 visit intend make within 4 month ahead , Taking part another clinical trial exclusion period previous clinical trial , Having receive , last 12 month , indemnity clinical trial high equal 4500 euro , Under legal protection ( guardianship , wardship ) deprive right follow administrative judicial decision , Presenting psychological linguistic incapability sign inform consent , Impossible contact case emergency , After V0 biological analysis subject consider non eligible study follow criterion : Fasting blood triglyceride &gt; 3.5 g/L ( 3.95 mmol/L ) , Blood ASAT , ALAT GGT ( Gamma Glutamyl Transferase ) &gt; 3xULN ( Upper Limit Normal ) , Blood urea &gt; 12.11 mmol/L ( value correspond 1.5xULN ) creatinine &gt; 125 µmol/L , Blood hsCRP &gt; 10 mg/L , Complete blood count clinically significant abnormality accord investigator . A rescreening occur 2 month exit study failure comply one exclusion criterion list .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>